TipRanks
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market
EMMA
Emmaus Life Sciences
RESEARCH TOOLSreports
Want to see EMMA full AI Analyst Report?

Emmaus Life Sciences (EMMA) Income Statement

89 Followers

Emmaus Life Sciences Income Statement

Last quarter (Q2 2026), Emmaus Life Sciences's total revenue was $6.32M, an increase of 124.28% from the same quarter last year. In Q2, Emmaus Life Sciences's net income was $1.34M. See Emmaus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Jun 24Dec 22Mar 22
Total Revenue
$ 12.45M$ 16.65M$ 29.60M$ 18.39M$ 20.61M
Gross Profit
$ 11.60M$ 15.45M$ 28.25M$ 15.80M$ 17.30M
Operating Expenses
$ 11.37M$ 17.35M$ 24.71M$ 22.39M$ 23.43M
Depreciation and Amortization
$ 39.00K$ 22.00K$ 32.00K$ 53.00K$ 59.00K
EBITDA
$ -310.00K$ -910.00K$ 3.62M$ -5.50M$ -12.76M
Operating Income
$ 231.00K$ -1.89M$ 3.54M$ -6.59M$ -6.13M
Other Income/Expenses
$ -7.71M$ -4.53M$ -7.33M$ -3.98M$ -9.79M
Pretax Income
$ -7.48M$ -6.42M$ -3.79M$ -10.56M$ -15.92M
Net Income
$ -7.49M$ -6.45M$ -3.73M$ -10.63M$ -15.95M
Per Share Metrics
Basic EPS
$ -0.12$ -0.10$ -0.07$ -0.21$ -0.32
Diluted EPS
$ -0.12$ -0.10$ -0.07$ -0.21$ -0.32
Weighted Average Shares Outstanding
 64.04M 63.23M 53.10M 49.44M 49.25M
Weighted Average Shares Outstanding (Diluted)
 64.04M 63.23M 53.10M 49.44M 49.25M
Currency in USD

Emmaus Life Sciences Earnings and Revenue History